Notice of Change to RFA-AG-20-004 “Alzheimer's Disease Research Centers (P30 Clinical Trial Not Allowed)”

Notice Number: NOT-AG-19-013

Key Dates
Release Date: March 25, 2019

Related Announcements
RFA-AG-20-004

Issued by
National Institute on Aging (NIA)

Purpose

The purpose of this Notice is to inform interested applicants that the application types allowed for Funding Opportunity Announcement (FOA) RFA-AG-20-004 “Alzheimer's Disease Research Centers (P30 Clinical Trial Not Allowed)" have been modified to include only New applications.

Currently Reads:

Part 2, Section II, Award Information
Application Types Allowed: 
New, Resubmission, Renewal

Part 2, Section V. Application Review Information

1. Criteria

Resubmissions

For Resubmissions, the committee will evaluate the application as now presented, taking into consideration the responses to comments from the previous scientific review group and changes made to the project.

Renewals

For Renewals, the committee will consider the progress made in the last funding period.

Revisions

Not Applicable

Revised to Read:

Part 2, Section II, Award Information
Application Types Allowed: 
New

Part 2, Section V. Application Review Information

1. Criteria

Resubmissions

Not Applicable

Renewals

Not Applicable

Revisions

Not Applicable

In addition, reflecting this change in application types, an "Introduction to Application" section is no longer allowed for the components of the announcement.

All other aspects of the FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Cerise L. Elliott, Ph.D.
National Institute on Aging (NIA)
Telephone: 301-496-9350
Email: elliottce@nih.gov